UMOD and systemic lupus erythematosus: Another limitation of our study is that we included SLE patients with a long disease duration; therefore, we propose the potential use of this biomarker as a new parameter of renal flares, but we have no information regarding serum levels of uromodulin in recent-onset SLE patients.